Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-15

Clinical Trial Update: A Study of FB1003 in Healthy and Osteoarthritis Pain Subjects [Phase 1]

View source ↗

Summary

This is a Phase 1 trial update for FB1003 in healthy volunteers and osteoarthritis pain subjects. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FB1003

Snippet

Sponsor: 4B Technologies Limited | Conditions: Healthy Volunteers | Phase 1 | Status: RECRUITING